First Time Loading...

Novo Nordisk A/S
CSE:NOVO B

Watchlist Manager
Novo Nordisk A/S Logo
Novo Nordisk A/S
CSE:NOVO B
Watchlist
Price: 854.7 DKK 0.48%
Updated: May 6, 2024

Novo Nordisk A/S
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Novo Nordisk A/S
EPS (Diluted) Peer Comparison

Comparables:
HLUN A
ALK B

Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Novo Nordisk A/S
CSE:NOVO B
EPS (Diluted)
kr18
CAGR 3-Years
27%
CAGR 5-Years
18%
CAGR 10-Years
15%
H Lundbeck A/S
CSE:HLUN A
EPS (Diluted)
kr2
CAGR 3-Years
13%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ALK-Abello A/S
CSE:ALK B
EPS (Diluted)
kr2
CAGR 3-Years
171%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Novo Nordisk A/S's EPS (Diluted)?
EPS (Diluted)
18.6 DKK

Based on the financial report for Dec 31, 2023, Novo Nordisk A/S's EPS (Diluted) amounts to 18.6 DKK.

What is Novo Nordisk A/S's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
15%

Over the last year, the EPS (Diluted) growth was 52%. The average annual EPS (Diluted) growth rates for Novo Nordisk A/S have been 27% over the past three years , 18% over the past five years , and 15% over the past ten years .